Hoxworth Blood Center honored by City of Cincinnati leadership for 85 years of serving the greater Cincinnati community
Hoxworth Blood Center, University of Cincinnati was honored with a resolution by City of Cincinnati leadership at City Hall on January 31, 2024 for Hoxworth’s 85 years of dedicated service to the greater Cincinnati community.
Hoxworth Blood Center celebrated their 85th anniversary on December 10, 2023 and is currently the oldest operating blood center in the nation.
Hoxworth is the sole supplier of blood products to more than 30 hospitals and medical centers across 18 counties in Ohio, Kentucky, and Indiana.
Hoxworth Blood Center would like to thank City of Cincinnati leadership, including Mayor Aftab Pureval and Vice-Mayor Jan Michelle Lemon-Kearney, as well as blood recipient and Hoxworth advocate, Sister Keli, for spreading awareness on blood donation and continuously supporting Hoxworth's mission in Saving Lives Close to Home.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.